Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The developmental record: reliability and validity in a clinical population.

C Brems1, D Kowalski, J Powell

  • 1University of Oklahoma Health Sciences Center.

American Journal of Mental Retardation : AJMR
|May 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study.

ESMO open·2025
Same author

Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial.

ESMO open·2021
Same author

ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac Repolarization.

Clinical pharmacology and therapeutics·2017
Same author

Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2015

The Developmental Record shows high internal reliability for adults with developmental disabilities. However, its validity is questionable, as factor analysis did not confirm its subscale structure.

Area of Science:

  • Psychometrics
  • Developmental Psychology
  • Clinical Assessment

Background:

  • The Developmental Record has been utilized since 1974 for assessing adults with developmental disabilities.
  • No recent studies have confirmed the clinical utility of the Developmental Record through reliability and validity testing.
  • This instrument is particularly prevalent in the midwestern and southwestern United States.

Purpose of the Study:

  • To evaluate the reliability and validity of the Developmental Record.
  • To determine the clinical usefulness of the Developmental Record for adults with developmental disabilities.

Main Methods:

  • A total of 1,069 Developmental Record protocols were collected from archival records.
  • The study employed factor analysis to examine the instrument's subscale structure.

Related Experiment Videos

  • Internal reliabilities were calculated to assess the consistency of the instrument.
  • Main Results:

    • The Developmental Record demonstrated high internal reliabilities.
    • Validity of the instrument was found to be questionable.
    • Factor analysis did not confirm the proposed subscale structure of the Developmental Record.

    Conclusions:

    • While the Developmental Record exhibits strong internal consistency, its validity is a concern.
    • The lack of confirmed subscale structure suggests potential issues with the instrument's construct validity.
    • Further research is needed to clarify the clinical utility and psychometric properties of the Developmental Record.